Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers

Conditions:   Rotavirus Infections;   Rotavirus Gastroenteritis Interventions:   Biological: Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine;   Biological: High dose Recombinant Trivalent Subunit Rotavirus Vaccine;   Biological: Placebo Sponsors:   MAXVAX Biotechnology Limited Liability Company;   Henan Center for Disease Control and Prevention Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials